Pharmaceutical Care (Allemann)

Wiss, Florine M. et al. (2024) ‘Associations between (pharmaco-)genetic markers and postoperative pain after inguinal hernia repair – a prospective study protocol’, BMC Medical Genomics, 17(1). Available at: https://doi.org/10.1186/s12920-024-02064-6.

Wiss, Florine M. et al. (2024) ‘Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical Practice’, Genes, 15(7). Available at: https://doi.org/10.3390/genes15070862.

Stäuble, Céline K. et al. (2024) ‘A Clinical Practice Perspective on the Evaluation of OATP1B1‐associated Drug Interactions’, Clinical Pharmacology & Therapeutics [Preprint]. Available at: https://doi.org/10.1002/cpt.3247.

Alexa, Jennifer (2024) Pharmacy Consultation Guide. 2 edn. 2. W. Kohlhammer GmbH, p. 135. Available at: https://doi.org/10.17433/978-3-17-041139-5.

Amiesimaka, Obreniokibo Ibifubara et al. (2024) ‘Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis’, British Journal of Clinical Pharmacology [Preprint]. Available at: https://doi.org/10.1111/bcp.16069.

Arnet, Isabelle et al. (2024) ‘Inconclusiveness of psychometric testing of medication adherence questionnaires’, European Journal of Clinical Pharmacology, 80, pp. 1189–1195. Available at: https://doi.org/10.1007/s00228-024-03684-8.

Barbati, Selina et al. (2024) ‘Concordance between pharmacy dispensing and electronic monitoring data of direct oral anticoagulants - A secondary analysis of the MAAESTRO study’, Research in Social and Administrative Pharmacy, 20, pp. 1096–1101. Available at: https://doi.org/10.1016/j.sapharm.2024.08.090.

Barbati, Selina et al. (2024) ‘Initiation of oral hepatitis C virus treatment: Which barriers are pertinent for ambulatory individuals with a history of illicit substance use? A qualitative interview study’, Health Science Reports, 7. Available at: https://doi.org/10.1002/hsr2.1814.

Bollinger, Anna et al. (2024) ‘Pharmacogenotyping disproves genetic cause of drug-related problems in family history: a case report’, BMC Anesthesiology, 24(1). Available at: https://doi.org/10.1186/s12871-024-02797-y.

Hoarau, Damien et al. (2024) ‘Determinants of adherence to post-stroke/transient ischemic attack secondary prevention medications: A cohort study’, European Journal of Neurology [Preprint]. Available at: https://doi.org/10.1111/ene.16395.

Rekk, Katharina et al. (2024) ‘Relationship between electronically monitored adherence to direct oral anticoagulants and ischemic or hemorrhagic events after an initial ischemic stroke-A case control study’, PLoS ONE, 19. Available at: https://doi.org/10.1371/journal.pone.0301421.

Wiss, Florine M. et al. (2024) ‘Associations between (pharmaco-)genetic markers and postoperative pain after inguinal hernia repair – a prospective study protocol’, BMC Medical Genomics, 17. Available at: https://doi.org/10.1186/s12920-024-02064-6.

Alexa, J. M. and Bertsche, T. (2023) ‘An online cross-sectional survey of community pharmacists to assess information needs for evidence-based self-medication counselling’, International Journal of Clinical Pharmacy, 45(6), pp. 1452–1463. Available at: https://doi.org/10.1007/s11096-023-01624-7.

Bollinger, Anna et al. (2023) ‘Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report’, Pharmacogenomics, 24(14), pp. 739–746. Available at: https://doi.org/10.2217/pgs-2023-0122.

Alexa, Jennifer Maria, Richter, Matthias and Bertsche, Thilo (2023) ‘Enhancing Evidence-Based Pharmacy by Comparing the Quality of Web-Based Information Sources to the EVInews Database: Randomized Controlled Trial With German Community Pharmacists’, Journal of Medical Internet Research, 25, p. e45582. Available at: https://doi.org/10.2196/45582.

Bertsche, Thilo et al. (2023) ‘Self-care and self-medication as central components of healthcare in Germany – on the way to evidence-based pharmacy’, Exploratory Research in Clinical and Social Pharmacy, 9, p. 100257. Available at: https://doi.org/10.1016/j.rcsop.2023.100257.

Amador-Fernández, Noelia et al. (2023) ‘Clinical relevance and implementation into daily practice of pharmacist-prescribed medication for the management of minor ailments’, Frontiers in Pharmacology, 14. Available at: https://doi.org/10.3389/fphar.2023.1256172.

Arnet, I. et al. (2023) ‘Non-adherence and epileptic emergency—reasons and solutions’, Clinical Epileptology, null. Available at: https://doi.org/10.1007/s10309-023-00627-8.

Arnet, Isabelle et al. (2023) ‘Rescue analgesia for opioid-dependent individuals on opioid agonist treatment during hospitalization: adherence to guideline treatment’, Eur Add Res, pp. 1–11. Available at: https://doi.org/10.1159/000530266.

Bollinger, A. et al. (2023) ‘Severe systemic adverse reactions to ophthalmic timolol in a CYP2D6 homozygous *4 allele carrier: a case report’, Pharmacogenomics, 24, pp. 739–746. Available at: https://doi.org/10.2217/pgs-2023-0122.

Bollinger, Anna et al. (2023) ‘Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study.’, Pharmacogenomics and personalized medicine, 16, pp. 693–706. Available at: https://doi.org/10.2147/pgpm.s415259.

Dietrich, Fine et al. (2023) ‘Development and acceptance of a new adherence monitoring package to identify non-adherent patients with polypharmacy in primary care: a feasibility study.’, BMJ Open quality, 12(1), p. e002155. Available at: https://doi.org/10.1136/bmjoq-2022-002155.

do Prado, Luiza Siqueira et al. (2023) ‘Toward an Interdisciplinary Approach to Constructing Care Delivery Pathways From Electronic Health Care Databases to Support Integrated Care in Chronic Conditions: Systematic Review of Quantification and Visualization Methods’, Journal of Medical Internet Research, 25. Available at: https://doi.org/10.2196/49996.

Jeiziner, Chiara et al. (2023) ‘Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service.’, International journal of clinical pharmacy, p. https://doi.org/10.1007/s11096–023–01596–8. Available at: https://doi.org/10.1007/s11096-023-01596-8.

Messner, Kirstin et al. (2023) ‘Knowledge and attitudes of German and Swiss community pharmacists towards biologicals and biosimilars – a prospective survey before and after the COVID-19 pandemic’, BMC Health Services Research, 23. Available at: https://doi.org/10.1186/s12913-023-10475-x.

Tan, Michael et al. (2023) ‘Adherence patterns in antiseizure medications (ASM) influencing risk of Sudden Unexplained Death in Epilepsy (SUDEP): a data linkage study using dispensed prescriptions.’, Epilepsia, p. 10.1111/epi.17502. Available at: https://doi.org/10.1111/epi.17502.

Wiss, Florine M et al. (2023) ‘Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy.’, Journal of personalized medicine, 13(5), p. 829. Available at: https://doi.org/10.3390/jpm13050829.

Stäuble, Céline K. et al. (2022) ‘A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting’, Pharmacy, 10(4), p. 86. Available at: https://doi.org/10.3390/pharmacy10040086.

Bandiera, Carole et al. (2022) ‘Swiss Priority Setting on Implementing Medication Adherence Interventions as Part of the European ENABLE COST Action’, International Journal of Public Health, 67, p. 1605204. Available at: https://doi.org/10.3389/ijph.2022.1605204.

Baumgartner, Pascal C et al. (2022) ‘Development and testing of a framework for defining a strategy to address medication adherence during patient encounters in community pharmacies.’, Explor Res Clin Soc Pharm, 5, p. 100123. Available at: https://doi.org/10.1016/j.rcsop.2022.100123.

Baumgartner, Pascal C et al. (2022) ‘Delta T, a useful indicator for pharmacy dispensing data to monitor medication adherence’, Pharmaceutics, 14(1), p. 103. Available at: https://doi.org/10.3390/pharmaceutics14010103.

Dalli, Lachlan L et al. (2022) ‘Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN-SPIDERS.’, Br J Clin Pharm, 88(10), pp. 4427–4442. Available at: https://doi.org/10.1111/bcp.15391.

Dima, Alexandra L et al. (2022) ‘Methodological considerations on estimating medication adherence from self-report, electronic monitoring and electronic healthcare databases using the TEOS framework.’, British journal of clinical pharmacology, p. 10.1111/bcp.15375. Available at: https://doi.org/10.1111/bcp.15375.

Jeiziner, Chiara et al. (2022) ‘Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report.’, Pharmacogenomics and personalized medicine, 15, pp. 465–475. Available at: https://doi.org/10.2147/pgpm.s354011.

Rothen, Jean-Pierre et al. (2022) ‘Renal insufficiency and magnesium deficiency correlate with a decreased formation of biologically active cholecalciferol: a retrospective observational study.’, International journal of clinical pharmacy, p. 10.1007/s11096–022–01485–6. Available at: https://doi.org/10.1007/s11096-022-01485-6.

Stäuble, Céline K. et al. (2022) ‘A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting’, Pharmacy (Basel, Switzerland), 10(4), p. 86. Available at: https://doi.org/10.3390/pharmacy10040086.

Stäuble, Céline K et al. (2022) ‘Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene.’, Frontiers in psychiatry, 13, p. 942268. Available at: https://doi.org/10.3389/fpsyt.2022.942268.

Stäuble, Céline K et al. (2022) ‘Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene.’, Frontiers in psychiatry, 13, p. 13. Available at: https://doi.org/10.3389/fpsyt.2022.942268.

Wittwer, Nina L et al. (2022) ‘Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database.’, Pharmacogenomics and personalized medicine, 15, pp. 967–976. Available at: https://doi.org/10.2147/pgpm.s382214.

Yous, Tamara et al. (2022) ‘Development of a Protocol Using the Delphi Method for the ad interim Supply of Hormonal Contraceptives in Swiss Pharmacies.’, Pharmacy (Basel, Switzerland), 10(6), p. 10.3390/pharmacy10060168. Available at: https://doi.org/10.3390/pharmacy10060168.

Dima, Alexandra L et al. (2021) ‘TEOS: A framework for constructing operational definitions of medication adherence based on Timelines-Events-Objectives-Sources.’, British journal of clinical pharmacology, 87(6), pp. 2521–2533. Available at: https://doi.org/10.1111/bcp.14659.

Jeiziner, Chiara et al. (2021) ‘Enriching Medication Review with a Pharmacogenetic Profile - A Case of Tamoxifen Adverse Drug Reactions.’, Pharmacogenomics and personalized medicine, 14, pp. 279–286. Available at: https://doi.org/10.2147/pgpm.s285807.

Stäuble, Céline K et al. (2021) ‘Pharmacogenetics in Pharmaceutical Care-Piloting an Application-Oriented Blended Learning Concept.’, Pharmacy (Basel, Switzerland), 9(3), p. 152. Available at: https://doi.org/10.3390/pharmacy9030152.

Stäuble, Céline K et al. (2021) ‘Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial.’, Trials, 22(1), p. 919. Available at: https://doi.org/10.1186/s13063-021-05724-5.

Stäuble, Céline K. et al. (2021) ‘Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying; CYP2D6; *4 Variants: A Case Report’, International Journal of Molecular Siences, 22(12), p. 6480. Available at: https://doi.org/10.3390/ijms22126480.

Stäuble, Céline K et al. (2021) ‘Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report.’, Life (Basel, Switzerland), 11(7), p. 673. Available at: https://doi.org/10.3390/life11070673.

Yous, Tamara, Allemann, Samuel and Lutters, Monika (2021) ‘Physicians” Opinion Regarding Extended Access to Hormonal Contraception in Switzerland.’, Pharmacy (Basel, Switzerland), 9(4), p. 184. Available at: https://doi.org/10.3390/pharmacy9040184.

Martinez-De la Torre, Adrian et al. (2020) ‘National Poison Center Calls Before vs After Availability of High-Dose Acetaminophen (Paracetamol) Tablets in Switzerland.’, JAMA network open, 3(10), p. e2022897. Available at: https://doi.org/10.1001/jamanetworkopen.2020.22897.

Siqueira do Prado, Luiza et al. (2020) ‘Quantification and visualisation methods of data-driven chronic care delivery pathways: protocol for a systematic review and content analysis.’, BMJ open, 10(3), p. e033573. Available at: https://doi.org/10.1136/bmjopen-2019-033573.

Stäuble, Céline K et al. (2020) ‘Nonresponse to high-dose bupropion for depression in a patient carrying; CYP2B6; *6 and; CYP2C19; *17 variants: a case report.’, Pharmacogenomics, 21(16), pp. 1145–1150. Available at: https://doi.org/10.2217/pgs-2020-0087.

Yous, Tamara, Allemann, Samuel and Lutters, Monika (2020) ‘Extended Access to Hormonal Contraception in Pharmacies: A Survey among Swiss Pharmacists.’, Pharmacy (Basel, Switzerland), 8(4), p. 210. Available at: https://doi.org/10.3390/pharmacy8040210.

Alexa, Jennifer (2019) Pharmacy Consultation Guide. 1 edn. 1. Stuttgart: W. Kohlhammer GmbH, p. 114. Available at: https://doi.org/10.17433/978-3-17-035969-7.

Dima, Alexandra, Allemann, Samuel and Dediu, Dan (2019) ‘AdhereR: An Open Science Approach to Estimating Adherence to Medications Using Electronic Healthcare Databases.’, Studies in health technology and informatics, 264, pp. 1451–1452. Available at: https://doi.org/10.3233/shti190479.

Rouzé, Héloïse et al. (2019) ‘Adherence to long-term therapies in cystic fibrosis: a French cross-sectional study linking prescribing, dispensing, and hospitalization data.’, Patient preference and adherence, 13, pp. 1497–1510. Available at: https://doi.org/10.2147/ppa.s211769.